Home - Products - Microbiology/Virology - HIV - Elsulfavirine

Elsulfavirine

CAS No. 868046-19-9

Elsulfavirine( Elpida | VM-1500 )

Catalog No. M24876 CAS No. 868046-19-9

Elsulfavirine is an HIV-1 infection reverse transcriptase inhibitor. It is a new anti-HIV drug.

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
5MG	177	In Stock
10MG	290	In Stock
25MG	492	In Stock
50MG	709	In Stock
100MG	972	In Stock
200MG	Get Quote	In Stock
500MG	Get Quote	In Stock
1G	Get Quote	In Stock

Group Booking Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

Elsulfavirine
Note

Research use only, not for human use.
Brief Description

Elsulfavirine is an HIV-1 infection reverse transcriptase inhibitor. It is a new anti-HIV drug.
Description

Elsulfavirine is an HIV-1 infection reverse transcriptase inhibitor. It is a new anti-HIV drug.
In Vitro

——
In Vivo

——
Synonyms

Elpida | VM-1500
Pathway

Microbiology/Virology
Target

HIV
Recptor

HIV-1
Research Area

——
Indication

——

Chemical Information

CAS Number

868046-19-9
Formula Weight

629.28
Molecular Formula

C24H17BrCl2FN3O5S
Purity

>98% (HPLC)
Solubility

DMSO:60 mg/mL?(95.35 mM;?Need ultrasonic)
SMILES

CCC(NS(c(cc1)cc(Cl)c1NC(Cc(ccc(Br)c1Oc2cc(Cl)cc(C#N)c2)c1F)=O)(=O)=O)=O
Chemical Name

——

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

1.Rai MA, et al. Emerging reverse transcriptase inhibitors for HIV-1 infection. Expert Opin Emerg Drugs. 2018 Jun;23(2):149-157.

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

Decanoyl-RVKR-CMK

Subtilisin/Kex2p-like proprotein convertase inhibitor; blocks activity of all seven convertases (PC1, PC2, PC4, PACE4, PC5, PC7 and furin). Abolishes proET-1 processing in endothelial cells; inhibits regulated secretion of the neuronal polypeptide VGF in PC12 cells.
Diphyllin

Diphyllin could be characterized as a new V-ATPase inhibitor in treating gastric cancer and inhibiting the phosphorylation of LRP6 in Wnt/β-catenin signaling.
Raltegravir

A potent, selective, orally bioavailable HIV-integrase inhibitor with IC50 of 15 nM.

Sign In Join Free